•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Cypherpunk Technologies Reports First Quarter 2026 Financial Results
Cypherpunk Increases its Zcash Stake, Launches New Website and Investor Dashboard
Cypherpunk Reports Full Year 2025 Financial Results
Cypherpunk Makes $5M Investment into Zcash Open Development Lab (ZODL)
Cypherpunk Adds Arjun Khemani as Strategic Advisor
Josh Swihart, ECC CEO, Joins Cypherpunk as Strategic Advisor
Cypherpunk Technologies Inc. (CYPH) Leap Therapeutics, Inc. - Shareholder/Analyst Call Prepared Remarks Transcript
Cypherpunk Technologies (formerly Leap Therapeutics) Reports Third Quarter 2025 Financial Results
Leap Therapeutics Rebrands as Cypherpunk; Expands Leadership Team to Drive New Zcash Treasury Strategy
NASDAQ Approves SOL Strategies Global Select Market Listing
Sol Strategies Monthly Update
NASDAQ Listing Moves Forward as SOL Strategies Sets Record Date for Stock Consolidation
SOL Strategies to Be Featured in Exclusive Cantor Fireside Chat
ARK Invest's Digital Asset Revolutions Fund Selects SOL Strategies as Its New Solana Staking Provider
NASDAQ Listing Moves Forward as SOL Strategies Board Approves Stock Consolidation
SOL Strategies Announces Strategic Board Transition and Leadership Appointments
Sol Strategies Monthly Update Highlighting Record Solana Staked and 40F Filing with SEC as Strategic Step Towards Nasdaq Listing
CEO.CA's Inside the Boardroom: 3.5M Solana Tokens Under Management - Sol Strategies CTO on Validator Revenue Model
SOL Strategies Files Form 40-F Registration Statement with the SEC
Sol Strategies: Q2 Progress Doesn't Change The Core Risks